Based on the Fortis Healthcare Limited stock forecast from 2 analysts, the average analyst target price for Fortis Healthcare Limited is INR 435.00 over the next 12 months. Fortis Healthcare Limited’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Fortis Healthcare Limited is Bearish, which is based on 3 positive signals and 9 negative signals. At the last closing, Fortis Healthcare Limited’s stock price was INR 430.20. Fortis Healthcare Limited’s stock price has changed by -0.83% over the past week, +7.21% over the past month and +60.97% over the last year.
No recent analyst target price found for Fortis Healthcare Limited
No recent average analyst rating found for Fortis Healthcare Limited
Company Overview Fortis Healthcare Limited
Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Nepal, Sri Lanka, and internationally. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetology/endocrinology, emergency and trauma, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplanrheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties, as well as ear, nose, and throat. The company was founded in 1995 and is based in Gurugram, India. Read Less
Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Nepal, Sri Lanka, and internationally. Its healthcare verticals comprise hospitals, diagnostics, and day care special...Read More
Frequently Asked Questions About Fortis Healthcare Limited (FORTIS:NSE) Stock
Based on ratings from 2 analysts Fortis Healthcare Limited's stock is Buy . Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and 1 hold ratings.
FORTIS:NSE stock's dividend yield is 0.24%.
Our analysis grades FORTIS:NSE stock's dividend yield at F. This means that FORTIS:NSE stock's dividend yield is above 50% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this FORTIS:NSE may be a average dividend stock for its sector.
Based on targets from 2 analysts, the average taret price for FORTIS:NSE is INR 435.00 over the next 12 months. The maximum analyst target price is INR 480 while the minimum anlayst target price is INR 390.
FORTIS:NSE stock's Price/Earning ratio is 57.48.
Our analysis grades FORTIS:NSE stock's Price / Earning ratio at F. This means that FORTIS:NSE stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this FORTIS:NSE may be fairly valued for its sector
The last closing price of FORTIS:NSE's stock was INR 430.20.
The most recent market capitalization for FORTIS:NSE is INR 317.23B.
Based on targets from 2 analysts, the average taret price for FORTIS:NSE is projected at INR 435.00 over the next 12 months.
This means that FORTIS:NSE's stock price may go up by +1.12% over the next 12 months.
We can't find any ETFs which contains Fortis Healthcare Limited's stock.
As per our most recent records Fortis Healthcare Limited has 13,010 Employees.
Fortis Healthcare Limited's registered address is Tower A, Gurugram, India, 122001.
You can get more information about it from Fortis Healthcare Limited's website at https://www.fortishealthcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for FORTIS:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
